CID 135413535

Valganciclovir

Structural Information

Molecular Formula
C14H22N6O5
SMILES
CC(C)[C@@H](C(=O)OCC(CO)OCN1C=NC2=C1N=C(NC2=O)N)N
InChI
InChI=1S/C14H22N6O5/c1-7(2)9(15)13(23)24-4-8(3-21)25-6-20-5-17-10-11(20)18-14(16)19-12(10)22/h5,7-9,21H,3-4,6,15H2,1-2H3,(H3,16,18,19,22)/t8?,9-/m0/s1
InChIKey
WPVFJKSGQUFQAP-GKAPJAKFSA-N
Compound name
[2-[(2-amino-6-oxo-1H-purin-9-yl)methoxy]-3-hydroxypropyl] (2S)-2-amino-3-methylbutanoate
Related CIDs

2D Structure

compound 2d structure
8
Annotation Hits

1263
References

18464
Patents

354.16516 Da
Monoisotopic Mass

-1.5
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 355.17244 179.4
[M+Na]+ 377.15438 185.5
[M-H]- 353.15788 176.4
[M+NH4]+ 372.19898 187.3
[M+K]+ 393.12832 183.3
[M+H-H2O]+ 337.16242 170.6
[M+HCOO]- 399.16336 194.4
[M+CH3COO]- 413.17901 215.1
[M+Na-2H]- 375.13983 178.9
[M]+ 354.16461 181.4
[M]- 354.16571 181.4
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

literature stripe

Patent stripe

patents stripe